Pathogenic Age-Associated B Cells for Environmental and Agricultural Applications

Publication ID: 24-11857563_0002_PTD
Published: October 28, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Pathogenic Age-Associated B Cells for Environmental and Agricultural Applications,” Published Technical Disclosure No. 24-11857563_0002_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857563_0002_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,563.

Summary of the Inventive Concept

This inventive concept leverages the core technology of targeting pathogenic age-associated B cells to develop novel applications in environmental monitoring, agricultural optimization, and personalized skincare, expanding the original patent's scope beyond autoimmune disease treatment.

Background and Problem Solved

The original patent focused on treating autoimmune diseases by targeting pathogenic age-associated B cells. However, the limitations of this approach lie in its narrow focus on human health. This new inventive concept addresses the need for innovative solutions in environmental monitoring, agricultural optimization, and personalized skincare, where the unique properties of pathogenic age-associated B cells can be harnessed to create impactful technologies.

Detailed Description of the Inventive Concept

The new inventive concept comprises a range of applications that utilize pathogenic age-associated B cells as biosensors, biostimulants, or biomarkers. In environmental monitoring, these biosensors detect and respond to specific pollutants, enabling real-time monitoring of environmental pollution. In agricultural optimization, the biostimulants enhance plant growth and resistance to disease, increasing crop yields. In personalized skincare, the biomarkers identify specific skin types and conditions, enabling the creation of customized skincare products. These applications are made possible by the unique properties of pathogenic age-associated B cells, which can be engineered to respond to specific stimuli and provide accurate, real-time data.

Novelty and Inventive Step

The new claims introduce a paradigm shift in the application of pathogenic age-associated B cells, moving beyond autoimmune disease treatment to address pressing issues in environmental monitoring, agricultural optimization, and personalized skincare. The inventive step lies in recognizing the potential of these cells to serve as biosensors, biostimulants, or biomarkers, and developing novel systems and methods that harness their unique properties.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include using pathogenic age-associated B cells to detect and respond to other environmental pollutants, or to optimize crop yields in specific agricultural contexts. Variations could also involve integrating these cells with other technologies, such as machine learning algorithms or IoT devices, to create more sophisticated monitoring and optimization systems.

Potential Commercial Applications and Market

The potential commercial applications of this inventive concept are vast, with opportunities in environmental monitoring, agricultural optimization, and personalized skincare. The target industries include environmental consulting, agricultural technology, and cosmetics, with potential partnerships with companies, research institutions, and government agencies.

Field of Art

Cellular biotechnology with specialization in immunological cell engineering, biomarker development, and adaptive cellular systems with expertise in molecular biology, genetic engineering, and cellular signal transduction

Person of Ordinary Skill (PHOSITA) Profile

A researcher or biotechnologist with advanced degree (PhD/MS) in immunology or molecular biology, capable of understanding cellular manipulation techniques, signal transduction pathways, and cross-disciplinary applications of cellular technologies

Obviousness Rationale

A PHOSITA would recognize that pathogenic age-associated B cells represent a versatile cellular platform with inherent signaling and response capabilities that can be readily adapted across multiple domains beyond their original medical context. The source patent's fundamental disclosure of cellular targeting and manipulation provides a clear technological foundation for exploring alternative applications in environmental monitoring, agricultural optimization, and diagnostic technologies. The PTD's variations represent predictable extensions of the core cellular engineering principles established in the original patent.

Obvious Combinations & Variations

Source Patent Element
Targeting and manipulating pathogenic age-associated B cells for disease intervention
PTD Variation
Using same cells as environmental biosensors for pollutant detection
Obviousness Reasoning
Known cellular engineering techniques allow repurposing of cellular response mechanisms across different detection contexts, representing a predictable technological adaptation
Source Patent Element
Genetic modification of B cells to respond to specific cellular signals
PTD Variation
Engineering B cells to detect and respond to agricultural stress conditions
Obviousness Reasoning
Cellular signal transduction principles are transferable across biological systems, making agricultural application a logical design choice
Source Patent Element
Identifying cellular biomarkers for diagnostic purposes
PTD Variation
Utilizing B cell biomarkers for personalized skincare product development
Obviousness Reasoning
Diagnostic cellular characterization techniques are directly applicable to identifying physiological variations across different tissue contexts
Source Patent Element
Methods of detecting and characterizing cellular responses
PTD Variation
Creating networked cellular systems for tracking invasive species spread
Obviousness Reasoning
Cellular response monitoring represents a generalizable technological approach adaptable to multiple ecological and environmental tracking scenarios
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857563, a person having ordinary skill in the art would find the variations disclosed in the Published Technical Disclosure to represent obvious extensions of the fundamental cellular engineering principles established in the source patent, thereby rendering potential claims directed to these variations anticipated and/or obvious under 35 U.S.C. ยง 103.

Original Patent Information

Patent NumberUS 11,857,563
TitleInhibition of expansion and function of pathogenic age-associated B cells and use for the prevention and treatment of autoimmune disease
Assignee(s)NEW YORK SOCIETY FOR THE RELIEF OF THE RUPTURED AND CRIPPLED, MAINTAINING THE HOSPITAL FOR SPECIAL SURGERY